Showing results (11-20 of 289) with videos related to
Sort By:
Pageof 29
Oral Oncology|April 23, 2013
Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: a practical approach to clinical decision makingR Michael Tuttle, Mona M SabraEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 29, 2012
Recombinant human thyroid-stimulating hormone to stimulate 131-I uptake for remnant ablation and adjuvant therapyMona M Sabra, R Michael TuttleEndocrinology and Metabolism Clinics of North America|June 4, 2014
Update on differentiated thyroid cancer stagingDenise P Momesso, R Michael TuttleThe Journal of Clinical Endocrinology and Metabolism|March 16, 2019
Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-UpR Michael Tuttle, Ali S AlzahraniIndian Journal of Surgical Oncology|April 25, 2022
Nuances in the Surgical Management of Thyroid CancerAshok R Shaha, R Michael TuttleSurgery|November 11, 2017
Editorial: Risk of disease progression during active surveillance of papillary thyroid cancerAshok R Shaha, R Michael TuttleRambam Maimonides Medical Journal|February 18, 2016
A Risk-adapted Approach to Follow-up in Differentiated Thyroid CancerValentina D Tarasova, R Michael TuttleGland Surgery|February 7, 2024
Active surveillance for micropapillary thyroid carcinoma: a clinical reviewAshok R Shaha, R Michael TuttleEndocrine-Related Cancer|January 11, 2023
Percutaneous ablation of low-risk papillary thyroid cancerR Michael Tuttle, Duan Li, Fourat RidouaniExpert Review of Endocrinology & Metabolism|July 31, 2018
A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical managementR Michael Tuttle, Ling Zhang, Ashok ShahaPageof 29